Expert Interview
Examining Tivdak (tisotumab vedotin) for recurrent or metastatic cervical cancer following chemotherapy progression
Ticker(s): SGENGynecological oncologist
Roughly how many patients with cervical cancer do you currently manage?
Added By: c_adminDo you prescribe Tivdak? How many patients?
Added By: c_adminWhat is the ideal patient type for this treatment?
Added By: c_adminAre You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
